Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
GlaxoSmithKline (GB:GSK)
LSE:GSK
GlaxoSmithKline (GSK) Stock Price & Analysis
114 Followers
GSK Stock Chart & Stats
Day’s Range0p - 0p
52-Week Range1,244.14p - 2,644.18p
Previous Close1,392.2p
Volume634.05K
Average Volume (3M)8.22M
Market Cap
£56.68B
Enterprise Value6.95T
Total Cash (Recent Filing)£7.68B
Total Debt (Recent Filing)£20.99B
Price to Earnings (P/E)4.0
Beta0.57
Next Earnings
Jul 26, 2023EPS Estimate
£0.35Last Dividend Ex-Date
May 18, 2023Dividend Yield
0.19 (0.01%)Share Statistics
EPS (TTM)3.51
Shares Outstanding4,311,343,341
10 Day Avg. Volume11,123,383
30 Day Avg. Volume8,223,391
Standard Deviation0.05
R-Squared0.29
Alpha0.00638
Financial Highlights & Ratios
Price to Book (P/B)-557.52
Price to Sales (P/S)505.68
Price to Cash Flow (P/CF)1575.40
P/FCF Ratio2140.20
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
1,572.50pPrice Target Upside14.76% Upside
Rating ConsensusHold
Number of Analyst Covering11
GlaxoSmithKline News
GSK FAQ
What was GlaxoSmithKline’s price range in the past 12 months?
GlaxoSmithKline lowest stock price was 1244.14p and its highest was 2644.18p in the past 12 months.
What is GlaxoSmithKline’s market cap?
Currently, no data Available
When is GlaxoSmithKline’s upcoming earnings report date?
GlaxoSmithKline’s upcoming earnings report date is Jul 26, 2023 which is in 56 days.
How were GlaxoSmithKline’s earnings last quarter?
GlaxoSmithKline released its earnings results on Apr 26, 2023. The company reported 0.37p earnings per share for the quarter, beating the consensus estimate of 0.333p by 0.037p.
Is GlaxoSmithKline overvalued?
According to Wall Street analysts GlaxoSmithKline’s price is currently Undervalued.
Does GlaxoSmithKline pay dividends?
GlaxoSmithKline pays a Annually dividend of 14p which represents an annual dividend yield of 4.4%. See more information on GlaxoSmithKline dividends here
What is GlaxoSmithKline’s EPS estimate?
GlaxoSmithKline’s EPS estimate is £0.35.
How many shares outstanding does GlaxoSmithKline have?
GlaxoSmithKline has 4,094,980,700 shares outstanding.
What happened to GlaxoSmithKline’s price movement after its last earnings report?
GlaxoSmithKline reported an EPS of 0.37p in its last earnings report, beating expectations of 0.333p. Following the earnings report the stock price went down -3.866%.
Which hedge fund is a major shareholder of GlaxoSmithKline?
Currently, no hedge funds are holding shares in GB:GSK
---
GlaxoSmithKline Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
1,572.50p (14.76% Upside)
1,572.50p (14.76% Upside)
Insider Transactions
Bought Shares
Worth £151.6K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-18.14%
12-Months-Change
Fundamentals
Return on Equity
31.82%
Trailing 12-Months
Asset Growth
-34.67%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
GlaxoSmithKline
In the pharmaceutical industry, GlaxoSmithKline ranks as one of the largest companies by total sales. The company wields its might across several therapeutic classes, including respiratory, oncology, and antiviral, as well as vaccines and consumer healthcare products. Glaxo uses joint ventures to gain additional scale in certain markets like HIV and consumer products.
---
Top 5 ETFs holding GSK
Vang FTSE 100 Ptg.Shs GBP
$138.54M
iShares MSCI United Kingdom ETF
$89.61M
UBS ETF MSCI UK Shs -A- Distribution
$57.20M
UBS (Lux) Fund Solutions SICAV - MSCI United Kingdom UCITS ETF A- Capitalisation
$57.20M
UBS (Lux) Fund Solutions SICAV - MSCI United Kingdom UCITS ETF (GBP) A-UKdis
$57.20M
Up to five ETFs with an Outperform Smart Score that hold GSK. The ETFs are listed according to market value of GSK within the ETF
---
---